Raffaella Petruzzelli

Pozzuoli, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A coordinated transcriptional program controls de novo Golgi biogenesis.

A coordinated transcriptional program controls de novo Golgi biogenesis.

Journal: The EMBO journal

Published: November 17, 2025

Copper in Human Health and Disease: Insights from Inherited Disorders.

Copper in Human Health and Disease: Insights from Inherited Disorders.

Journal: Physiology (Bethesda, Md.)

Published: November 10, 2025

Copper in Human Health and Disease: Insights from Inherited Disorders.

Copper in Human Health and Disease: Insights from Inherited Disorders.

Journal: Physiology (Bethesda, Md.)

Published: November 10, 2025

High-Calorie Diet Accelerates the Liver Tissue Degeneration and Induces Subcutaneous White-to-Brown Fat Conversion in Mice with a Single-Allele Atp7b Mutation.

High-Calorie Diet Accelerates the Liver Tissue Degeneration and Induces Subcutaneous White-to-Brown Fat Conversion in Mice with a Single-Allele Atp7b Mutation.

Journal: The Journal of nutrition

Published: March 12, 2025

Prion protein promotes copper toxicity in Wilson disease.

Prion protein promotes copper toxicity in Wilson disease.

Journal: Nature communications

Published: May 15, 2024

Effect of post-printing curing time on cytotoxicity of direct printed aligners: A pilot study.

Effect of post-printing curing time on cytotoxicity of direct printed aligners: A pilot study.

Journal: Orthodontics & craniofacial research

Published: May 13, 2024

A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.

A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.

Journal: Traffic (Copenhagen, Denmark)

Published: July 27, 2023

Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice.

Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice.

Journal: Molecular therapy. Methods & clinical development

Published: May 10, 2022

TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells.

TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells.

Journal: Cells

Published: December 07, 2021

Infantile ATP7B-Related End-Stage Liver Disease: An Exceptional Wilson Disease Phenotype From Consecutive Generations.

Infantile ATP7B-Related End-Stage Liver Disease: An Exceptional Wilson Disease Phenotype From Consecutive Generations.

Journal: JPGN reports

Published: March 04, 2021

Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.

Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 08, 2020

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin.

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin.

Journal: Cancers

Published: February 06, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026